TY - ADVS TI - CML: genetic paradigm of targeted therapy 1 AU - Deininger, Michael W. PY - 2015 DA - 2015/09/30 UR - https://hstalks.com/bs/3131/ AB - Typical clinical findings and phases of chronic myeloid leukaemia (CML), Philadelphia chromosome (juxtaposition & genomic anatomy BCR-ABL1), Target cells for transformation, Molecular driver for pathogenesis (BCR-ABL1 tyrosine kinase), Imatinib (inhibitor of BCR-ABL1) DB - The Biomedical & Life Sciences Collection SN - 2056-452X ID - 4040 PB - Henry Stewart Talks ER -